Quantum Biopharma (QNTM) Profit After Tax (2019 - 2026)
Quantum Biopharma (QNTM) reported Profit After Tax of -$13.6 million for Q1 2026, down 58.11% on a YoY basis from -$32.4 million in Q1 2025, and down 348.06% sequentially from -$3.0 million in Q4 2025.
Quantum Biopharma (QNTM) Profit After Tax (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Profit After Tax data on file, last reported at -$13.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 58.11% year-over-year to -$13.6 million; the trailing twelve-month figure through Mar 2026 stood at -$31.2 million (down 76.97% YoY), and the FY2025 full-year result was -$26.2 million, down 84.3% from the prior year.
- Profit After Tax declined to -$13.6 million in Q1 2026, from -$3.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $6.0 million in Q1 2022 to a low of -$13.6 million in Q1 2026.
- A 5-year average of -$4.6 million and a median of -$3.5 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 80.89% in 2024 and slumped 350.61% in 2025, its largest moves.
- Tracing QNTM's Profit After Tax over 5 years: stood at $6.0 million in 2022, then sank by 117.73% to -$1.1 million in 2023, then slumped by 97.33% to -$2.1 million in 2024, then sank by 44.71% to -$3.0 million in 2025, then sank by 348.06% to -$13.6 million in 2026.
- Business Quant data shows QNTM's Profit After Tax at -$13.6 million in Q1 2026, -$3.0 million in Q4 2025, and -$5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | -13.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.56 Mn |
| Dec 31, 2025 | -3.03 Mn |
| Sep 30, 2025 | -5.32 Mn |
| Jun 30, 2025 | -9.25 Mn |
| Mar 31, 2025 | -8.58 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | -3.83 Mn |
| Jun 30, 2024 | -3.11 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Sep 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -9.96 Mn |
| Mar 31, 2022 | 5.98 Mn |
| Jun 30, 2021 | -13.25 Mn |
| Mar 31, 2021 | 9.98 Mn |
| Sep 30, 2020 | -13.53 Mn |
| Jun 30, 2020 | -2.83 Mn |
| Mar 31, 2020 | -6.09 Mn |
| Dec 31, 2019 | -12.93 Mn |
| Sep 30, 2019 | -12.85 Mn |
| Jun 30, 2019 | -11.73 Mn |